Corporation Negotiation Pharmaceutical 
Peak Frameworks
SEPTEMBER 19, 2023
In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. What is a Shareholder? By virtue of their ownership, they possess a direct financial interest in the company's success.
Devensoft
MAY 25, 2023
Corporate restructuring can be a game-changer for any organization, whether it’s a merger, acquisition, or any other strategic move. From identifying the right targets to negotiating deals and integrating teams, there are several critical steps involved in executing a successful restructuring plan.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
How2Exit
MARCH 31, 2024
With a career spanning over a decade, Patrick has become an industry-agnostic specialist, facilitating financial diligence, quality of earnings, purchase price negotiation, and offering comprehensive partnership support to his clients. rn rn rn Emotional readiness and concessions are critical in M&A transactions.
Cooley M&A
OCTOBER 24, 2024
Alexion Pharmaceuticals (Del. September 2024), the Delaware Chancery Courts found buyers liable for failure to comply with negotiated earnout covenants – and in the latter case, awarded the plaintiffs more than $1 billion in damages. Alexion Pharmaceuticals , arose out of Alexion’s 2018 acquisition of a company called Syntimmune.
Cooley M&A
JANUARY 25, 2023
But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.
Devensoft
AUGUST 24, 2023
Mastering Operations, Cross-Selling, and Cost Efficiencies for Maximizing Value from Integrated Ventures The Power of Synergy and Value Creation Amidst the dynamic and fiercely competitive modern business arena, corporations continually strive to secure a distinct market advantage while fostering expansion.
Growth Business
OCTOBER 2, 2023
US-based funds showed themselves to be vigorously interested in expanding European and UK businesses, while large corporates invested into growth companies as a means of outsourcing R&D and innovation – patterns which are expected to be sustained this year. Tim Bird is a corporate partner and a member of the VC practice at Fieldfisher.
Expert insights. Personalized for you.
52 
Let's personalize your content